Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Reed’s Reports Third Quarter 2025 Results
-
Superior Group of Companies Reports Third Quarter 2025 Results
-
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely
-
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Ormat Technologies Reports Third Quarter 2025 Financial Results
-
Solid Biosciences Reports Third Quarter 2025 Financial Results and Provides Update on INSPIRE DUCHENNE Clinical Trial Progress and Planned Regulatory Discussions
-
Gaia Reports Third Quarter 2025 Results
-
TELA Bio Appoints William Plovanic to Board of Directors
-
James River Announces Third Quarter 2025 Results
-
Flux Power to Host Fiscal First Quarter 2026 Financial Results Conference Call on November 13, 2025
-
Glucotrack, Inc. Encourages Shareholders to Vote
-
ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
-
ThredUp Announces Third Quarter 2025 Results
-
Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution
-
EverQuote Announces Third Quarter 2025 Financial Results
-
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November
-
Tactile Systems Technology, Inc. Reports Third Quarter 2025 Financial Results
-
Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®
-
BBOT to Participate in the Jefferies Global Healthcare Conference in London
-
Mobile Infrastructure Announces Timing of Third Quarter 2025 Earnings Release and Conference Call
-
Pyxis Oncology to Participate in Upcoming Investor Conferences
-
BeautyHealth Appoints Philippe Schaison, PharmaD, to Board of Directors
-
Regeneron Announces Investor Conference Presentations
-
InnovAge Appoints Dr. Paul Taheri as Chief Medical Officer
-
Option Care Health to Participate in Upcoming Investor Conferences
-
Lakeland Fire + Safety Declares Cash Dividend for Fourth Quarter 2026
-
Nyxoah to Participate in the Stifel 2025 Healthcare Conference
-
Castle Biosciences Launches AdvanceAD-Tx™ to Help Guide Systemic Treatment Decision Making in Patients with Moderate-to-Severe Atopic Dermatitis
-
NurExone Accepted into ARMI’s BioFab Startup Lab Strengthening U.S Position in Regenerative Manufacturing
-
Navitas Semiconductor Announces Third Quarter 2025 Financial Results
-
Palm Club Design Group Opens Immersive New Jupiter Design Showroom
-
Gibson Energy Declares Dividend
-
Kura Oncology Receives Second $30 Million Development Milestone Payment in AML Menin Inhibitor Program With Kyowa Kirin
-
Inspire Medical Systems, Inc. Announces Third Quarter 2025 Financial Results and Updates 2025 Outlook
-
FibroGen to Report Third Quarter 2025 Financial Results
-
Sense Group Expands Service Coverage Across Ontario
-
Mdxhealth to Release Third Quarter 2025 Financial Results on November 12
-
Letter to Stockholders Issued by Diamondback Energy, Inc.
-
3-Year Renal Data in Adults with Hypoparathyroidism Treated with TransCon® PTH (Palopegteriparatide) to Be Shared at Kidney Week 2025
-
Xenon Reports Third Quarter 2025 Financial Results & Business Update
-
Diamondback Energy, Inc. Announces Third Quarter 2025 Financial and Operating Results
-
Letter to Stockholders Issued by Diamondback Energy, Inc.
-
Xenon Reports Third Quarter 2025 Financial Results & Business Update
-
Gibson Energy Delivers Record Throughput and Continued Growth Across Canadian and U.S. Terminals in Q3 2025
-
Syndax Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Invivyd to Host Third Quarter 2025 Financial Results and Corporate Update Call on November 6, 2025
-
Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Reports Third Quarter 2025 Financial and Operating Results; Announces Divestiture of Non-Permian Assets
-
Symbotic Announces Date for Reporting Fourth Quarter and Fiscal Year 2025 Financial Results
-
Biodesix Announces Third Quarter 2025 Results and Highlights
